Glaxosmithkline Pharmaceuticals reports marginal fall Q1 consolidated net profit

26 Jul 2022 Evaluate

Glaxosmithkline Pharmaceuticals has reported results for first quarter ended June 30, 2022.

The company has reported a marginal fall of 1.43% in its net profit at Rs 118.68 crore for the quarter under review as compared to Rs 120.40 crore for the same quarter in the previous year. However, total income of the company increased by 3.23% at Rs 757.25 crore for Q1FY23 as compared Rs 733.57 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a marginal fall of 1.49% in its net profit at Rs 119.28 crore for the quarter under review as compared to Rs 121.08 crore for the same quarter in the previous year. However, total income of the company increased by 3.01% at Rs 772.71 crore for Q1FY23 as compared Rs 750.10 crore for the corresponding quarter previous year.

Glaxosmithkline Phar Share Price

2311.50 -68.35 (-2.87%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×